 Marta Ceko
Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chronic Pain | 11 | 2024 | 248 | 2.560 |
Why?
| | Fibromyalgia | 8 | 2021 | 55 | 2.010 |
Why?
| | Cognition | 6 | 2024 | 1093 | 1.400 |
Why?
| | Cerebral Cortex | 5 | 2020 | 407 | 1.390 |
Why?
| | Magnetic Resonance Imaging | 16 | 2024 | 3348 | 1.260 |
Why?
| | Brain Mapping | 7 | 2024 | 562 | 1.140 |
Why?
| | Brain | 8 | 2024 | 2592 | 1.050 |
Why?
| | Pain | 6 | 2022 | 761 | 1.030 |
Why?
| | Pain Measurement | 6 | 2024 | 489 | 0.940 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2024 | 48 | 0.910 |
Why?
| | Virtual Reality Exposure Therapy | 1 | 2024 | 7 | 0.900 |
Why?
| | Back Pain | 1 | 2024 | 51 | 0.860 |
Why?
| | Reading | 1 | 2024 | 150 | 0.830 |
Why?
| | Connectome | 2 | 2021 | 83 | 0.680 |
Why?
| | Healthy Volunteers | 3 | 2020 | 204 | 0.650 |
Why?
| | Neural Pathways | 5 | 2021 | 288 | 0.550 |
Why?
| | Memory, Short-Term | 2 | 2016 | 255 | 0.510 |
Why?
| | Nociception | 2 | 2024 | 22 | 0.500 |
Why?
| | Low Back Pain | 2 | 2021 | 105 | 0.460 |
Why?
| | Memory Disorders | 1 | 2015 | 156 | 0.460 |
Why?
| | Task Performance and Analysis | 1 | 2015 | 174 | 0.460 |
Why?
| | Nerve Net | 2 | 2021 | 249 | 0.440 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2014 | 65 | 0.440 |
Why?
| | Placebo Effect | 3 | 2024 | 57 | 0.430 |
Why?
| | Benzamides | 1 | 2014 | 191 | 0.420 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2014 | 110 | 0.420 |
Why?
| | Cold Temperature | 1 | 2014 | 150 | 0.410 |
Why?
| | Polyradiculopathy | 1 | 2012 | 3 | 0.410 |
Why?
| | Prefrontal Cortex | 3 | 2024 | 293 | 0.400 |
Why?
| | Nerve Fibers | 1 | 2012 | 89 | 0.390 |
Why?
| | Analgesia | 3 | 2024 | 93 | 0.380 |
Why?
| | Piperazines | 1 | 2014 | 326 | 0.380 |
Why?
| | Hot Temperature | 1 | 2014 | 362 | 0.370 |
Why?
| | Pyrimidines | 1 | 2014 | 444 | 0.350 |
Why?
| | Pain Threshold | 3 | 2014 | 72 | 0.320 |
Why?
| | Emotions | 3 | 2021 | 536 | 0.300 |
Why?
| | Neuroimaging | 2 | 2024 | 273 | 0.290 |
Why?
| | Adult | 16 | 2024 | 35361 | 0.290 |
Why?
| | Pain Perception | 4 | 2014 | 40 | 0.260 |
Why?
| | Middle Aged | 11 | 2024 | 30977 | 0.240 |
Why?
| | Affect | 3 | 2024 | 287 | 0.230 |
Why?
| | Touch | 2 | 2016 | 35 | 0.230 |
Why?
| | Nociceptive Pain | 1 | 2024 | 5 | 0.230 |
Why?
| | Female | 19 | 2024 | 68162 | 0.230 |
Why?
| | Humans | 27 | 2024 | 128896 | 0.230 |
Why?
| | Catastrophization | 1 | 2024 | 11 | 0.230 |
Why?
| | Neurosciences | 1 | 2024 | 29 | 0.220 |
Why?
| | Young Adult | 9 | 2024 | 12286 | 0.210 |
Why?
| | Virtual Reality | 1 | 2024 | 51 | 0.210 |
Why?
| | Antineoplastic Agents | 1 | 2014 | 2038 | 0.210 |
Why?
| | Comprehension | 1 | 2024 | 167 | 0.200 |
Why?
| | Male | 15 | 2024 | 63146 | 0.200 |
Why?
| | Hypothalamus, Posterior | 1 | 2021 | 5 | 0.190 |
Why?
| | Periaqueductal Gray | 1 | 2021 | 16 | 0.190 |
Why?
| | Pulvinar | 1 | 2021 | 4 | 0.190 |
Why?
| | Escape Reaction | 1 | 2021 | 61 | 0.190 |
Why?
| | Superior Colliculi | 1 | 2021 | 37 | 0.180 |
Why?
| | Functional Neuroimaging | 1 | 2021 | 73 | 0.180 |
Why?
| | Deception | 1 | 2020 | 18 | 0.170 |
Why?
| | Amygdala | 1 | 2021 | 182 | 0.170 |
Why?
| | Image Processing, Computer-Assisted | 4 | 2018 | 739 | 0.160 |
Why?
| | Disclosure | 1 | 2020 | 109 | 0.160 |
Why?
| | Visual Analog Scale | 1 | 2018 | 29 | 0.150 |
Why?
| | Gray Matter | 2 | 2016 | 79 | 0.150 |
Why?
| | Fear | 1 | 2021 | 317 | 0.150 |
Why?
| | Behavior, Animal | 1 | 2021 | 482 | 0.150 |
Why?
| | Diffusion Tensor Imaging | 2 | 2015 | 68 | 0.140 |
Why?
| | Attitude to Health | 1 | 2020 | 424 | 0.130 |
Why?
| | Sensation Disorders | 1 | 2016 | 31 | 0.130 |
Why?
| | Proprioception | 1 | 2016 | 26 | 0.130 |
Why?
| | Central Nervous System Sensitization | 1 | 2016 | 5 | 0.130 |
Why?
| | Touch Perception | 1 | 2016 | 14 | 0.130 |
Why?
| | Ion Channels | 1 | 2016 | 126 | 0.130 |
Why?
| | Multimodal Imaging | 1 | 2016 | 107 | 0.130 |
Why?
| | Receptors, Opioid, mu | 1 | 2016 | 57 | 0.130 |
Why?
| | Gene Silencing | 1 | 2016 | 180 | 0.130 |
Why?
| | Treatment Outcome | 2 | 2024 | 10239 | 0.120 |
Why?
| | Cognitive Reserve | 1 | 2015 | 16 | 0.120 |
Why?
| | Zygapophyseal Joint | 1 | 2015 | 6 | 0.120 |
Why?
| | Pain Management | 2 | 2021 | 319 | 0.120 |
Why?
| | Rest | 1 | 2015 | 121 | 0.110 |
Why?
| | Imatinib Mesylate | 1 | 2014 | 67 | 0.110 |
Why?
| | Spine | 1 | 2015 | 155 | 0.110 |
Why?
| | Nerve Fibers, Unmyelinated | 1 | 2012 | 9 | 0.100 |
Why?
| | Yoga | 1 | 2013 | 30 | 0.100 |
Why?
| | Neurons, Afferent | 1 | 2012 | 88 | 0.100 |
Why?
| | Skin | 2 | 2014 | 737 | 0.100 |
Why?
| | Hyperalgesia | 1 | 2012 | 109 | 0.100 |
Why?
| | Qualitative Research | 1 | 2018 | 1192 | 0.100 |
Why?
| | Cognition Disorders | 1 | 2016 | 496 | 0.090 |
Why?
| | Case-Control Studies | 2 | 2020 | 3334 | 0.090 |
Why?
| | Dopamine | 1 | 2013 | 281 | 0.090 |
Why?
| | Neuronal Plasticity | 1 | 2012 | 256 | 0.080 |
Why?
| | Biomarkers | 1 | 2021 | 3874 | 0.080 |
Why?
| | Surveys and Questionnaires | 3 | 2020 | 5355 | 0.080 |
Why?
| | Naloxone | 2 | 2021 | 113 | 0.070 |
Why?
| | Models, Neurological | 2 | 2021 | 233 | 0.070 |
Why?
| | Physical Stimulation | 2 | 2016 | 74 | 0.060 |
Why?
| | Clinical Trials as Topic | 2 | 2020 | 1002 | 0.050 |
Why?
| | Analgesics | 1 | 2024 | 165 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2024 | 367 | 0.050 |
Why?
| | Oxygen | 2 | 2018 | 912 | 0.050 |
Why?
| | Cholecystokinin | 1 | 2021 | 14 | 0.050 |
Why?
| | Rats, Long-Evans | 1 | 2021 | 111 | 0.050 |
Why?
| | Aversive Agents | 1 | 2021 | 2 | 0.050 |
Why?
| | Facial Pain | 1 | 2021 | 11 | 0.050 |
Why?
| | Capsaicin | 1 | 2021 | 25 | 0.040 |
Why?
| | Animals | 3 | 2021 | 34628 | 0.040 |
Why?
| | Video Recording | 1 | 2021 | 161 | 0.040 |
Why?
| | Signal Transduction | 1 | 2014 | 4857 | 0.040 |
Why?
| | Photic Stimulation | 1 | 2021 | 238 | 0.040 |
Why?
| | Optogenetics | 1 | 2021 | 113 | 0.040 |
Why?
| | Visual Perception | 1 | 2021 | 161 | 0.040 |
Why?
| | Aged | 2 | 2016 | 22035 | 0.040 |
Why?
| | Taste | 1 | 2021 | 214 | 0.040 |
Why?
| | Genomics | 1 | 2023 | 715 | 0.040 |
Why?
| | Adolescent | 4 | 2021 | 20197 | 0.040 |
Why?
| | Meta-Analysis as Topic | 1 | 2018 | 163 | 0.030 |
Why?
| | Flumazenil | 1 | 2016 | 6 | 0.030 |
Why?
| | Body Water | 1 | 2016 | 19 | 0.030 |
Why?
| | Brain Chemistry | 1 | 2016 | 115 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2023 | 1334 | 0.030 |
Why?
| | Vibration | 1 | 2016 | 67 | 0.030 |
Why?
| | Vulvodynia | 1 | 2016 | 2 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2021 | 2073 | 0.030 |
Why?
| | Radiopharmaceuticals | 1 | 2016 | 167 | 0.030 |
Why?
| | Fatigue Syndrome, Chronic | 1 | 2016 | 15 | 0.030 |
Why?
| | Receptors, GABA-A | 1 | 2016 | 93 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2021 | 1840 | 0.030 |
Why?
| | Irritable Bowel Syndrome | 1 | 2016 | 28 | 0.030 |
Why?
| | Gene Transfer Techniques | 1 | 2016 | 159 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2021 | 1967 | 0.030 |
Why?
| | Mechanotransduction, Cellular | 1 | 2016 | 110 | 0.030 |
Why?
| | Positron-Emission Tomography | 1 | 2016 | 284 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1545 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2016 | 510 | 0.030 |
Why?
| | Postmenopause | 1 | 2016 | 366 | 0.030 |
Why?
| | Narcotic Antagonists | 1 | 2016 | 162 | 0.030 |
Why?
| | Dopamine D2 Receptor Antagonists | 1 | 2013 | 5 | 0.030 |
Why?
| | Sulpiride | 1 | 2013 | 5 | 0.030 |
Why?
| | Thermosensing | 1 | 2013 | 12 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2016 | 673 | 0.030 |
Why?
| | Phenylalanine | 1 | 2013 | 60 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 2016 | 778 | 0.030 |
Why?
| | Presynaptic Terminals | 1 | 2013 | 64 | 0.030 |
Why?
| | Receptors, Dopamine D2 | 1 | 2013 | 90 | 0.030 |
Why?
| | Rats | 1 | 2021 | 5236 | 0.030 |
Why?
| | Tyrosine | 1 | 2013 | 219 | 0.030 |
Why?
| | Mice | 2 | 2021 | 16543 | 0.020 |
Why?
| | White Matter | 1 | 2013 | 127 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2016 | 994 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2021 | 5270 | 0.020 |
Why?
| | Time Factors | 1 | 2021 | 6568 | 0.020 |
Why?
| | Attention | 1 | 2013 | 434 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2016 | 2700 | 0.020 |
Why?
| | Phenotype | 1 | 2016 | 3059 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2016 | 2767 | 0.020 |
Why?
| | Anxiety | 1 | 2013 | 947 | 0.020 |
Why?
| | Child | 1 | 2016 | 20824 | 0.010 |
Why?
|
|
Ceko's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|